Acceptability and Uptake of COVID-19 Vaccines among Pregnant and Lactating Women seeking services at a Tertiary Public Hospital in Kampala, Uganda

Author:

Katana Elizabeth B.1,Odongpiny Eva Agnes Laker2,Simbwa Brenda N.3,Nsubuga Edirisa J.4,Namayanja Josephine3,Muhindo Richard2,Kiiza Daniel2,Castelnuovo Barbara2,Ario Alex R.1,Waitt Catriona5

Affiliation:

1. Uganda National Institute of Public Health, Ministry of Health, Kampala, Uganda

2. Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda

3. Uganda National Expanded Programme on Immunization, Ministry of Health, Kampala, Uganda

4. National Public Health Emergency Operations Centre, Ministry of Health, Kampala, Uganda

5. Institute of Translational Medicine, Pharmacology Research Laboratories, University of Liverpool

Abstract

Abstract

Background Globally, several vaccines, including COVID-19 vaccines, have been routinely recommended during pregnancy and lactation. However, data on COVID-19 vaccine acceptability and uptake among pregnant and lactating women are limited in Sub-Saharan Africa. While COVID-19 is no longer a public health emergency it is important to take stock of lessons learnt to prepare for future health threats including those that disproportionately affect pregnant/lactating women. We aimed to assess acceptability and uptake of COVID-19 vaccines among pregnant and lactating women in Uganda. Methods This was a cross-sectional study conducted among 424 pregnant and lactating women, who were seeking maternal and child health care at Kawempe National Referral Hospital in Kampala. We obtained data on vaccine acceptability defined as willingness to accept vaccines using interviewer-administered questionnaires. In addition, we assessed vaccination status. Factors associated with COVID-19 vaccine acceptability and uptake were evaluated using modified Poisson regression. Results The mean age of the respondents was 26.9 years (SD = 5.7), ranging from 14–45 years. Among 424 respondents, 51.7% had received at least one dose of COVID-19 vaccine, 94.1% had received tetanus toxoid vaccine, and 48.3% regardless of their vaccination status, were willing to receive COVID-19 vaccines. Only 5/212(2.4%) had received COVID-19 vaccines while lactating with none having been received during pregnancy. Factors associated with COVID-19 vaccine uptake included history of testing for COVID-19 (aPR = 1.92, CI:1.46–2.54) and having a vaccinated household member (aPR = 1.34, CI:1.03–1.84). COVID-19 vaccine willingness was significantly associated with being a household head (aPR = 2.2, CI:1.12–4.27) and having a vaccinated household member (aPR = 1.33, CI:1.04–1.76). Conclusion The uptake and willingness to receive COVID-19 vaccines among pregnant and lactating women were generally low, with no participants receiving COVID-19 vaccines during pregnancy and very few during lactation. In contrast, the majority had received tetanus toxoid vaccines, indicating a disparity in vaccine acceptance. Factors such as undergoing COVID-19 testing and having a vaccinated household member positively influenced COVID-19 vaccine uptake and willingness. These findings highlight the need for targeted interventions to improve the acceptance and uptake of COVID-19 vaccines, during pregnancy and lactation.

Publisher

Springer Science and Business Media LLC

Reference22 articles.

1. Introduction of new vaccines for immunization in pregnancy - Programmatic, regulatory, safety and ethical considerations;Kochhar S;Vaccine,2019

2. Vaccination during pregnancy: current and possible future recommendations;Maertens K;Eur J Pediatr,2020

3. August, 05 JLR. Devex. 2021 [cited 2024 Apr 12]. Increasing calls to vaccinate pregnant women against COVID-19. https://www.devex.com/news/sponsored/increasing-calls-to-vaccinate-pregnant-women-against-covid-19-100542

4. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study;Villar J;JAMA Pediatr,2021

5. Safety & effectiveness of COVID-19 vaccines: A narrative review;Chirico F;Indian J Med Res,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3